Aviva PLC Bristol Myers Squibb CO Transaction History

Aviva PLC

$34.3 Billion
Q2 2024

A detailed history of Aviva PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aviva PLC holds 950,186 shares of BMY stock, worth $50.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

950,186

Previous 790,682 20.17%

Holding current value

$50.5 Million

Previous $42.9 Million 7.97%

% of portfolio

0.12%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$40.25 - $52.99 $6.42 Million - $8.45 Million	159,504 Added 20.17%	950,186 $39.5 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $912,627 - $1.03 Million	-19,021 Reduced 2.35%	790,682 $42.9 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $1.97 Million - $2.35 Million	-40,702 Reduced 4.79%	809,703 $41.5 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $6.3 Million - $7.04 Million	-108,781 Reduced 11.34%	850,405 $49.4 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $12.5 Million - $13.8 Million	195,646 Added 25.62%	959,186 $61.3 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $5.47 Million - $6.21 Million	-83,309 Reduced 9.84%	763,540 $52.9 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $4.63 Million - $5.48 Million	67,639 Added 8.68%	846,849 $60.9 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $4,820 - $2.85 Million	37,077 Added 5.0%	779,210 $55.4 Million
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $4.53 Million - $4.99 Million	62,366 Added 9.17%	742,133 $57.1 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $2.46 Million - $2.94 Million	-39,939 Reduced 5.55%	679,767 $49.6 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $1.71 Million - $1.99 Million	-31,858 Reduced 4.24%	719,706 $44.9 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $4.03 Million - $4.72 Million	-68,091 Reduced 8.31%	751,564 $44.5 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $5.01 Million - $5.45 Million	-80,904 Reduced 8.98%	819,655 $54.8 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $22.9 Million - $25.8 Million	-386,682 Reduced 30.04%	900,559 $56.9 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $2.34 Million - $2.65 Million	40,565 Added 3.25%	1,287,241 $79.8 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $1.79 Million - $1.99 Million	-31,230 Reduced 2.44%	1,246,676 $75.2 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $4.95 Million - $5.79 Million	90,359 Added 7.61%	1,277,906 $75.1 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $2.94 Million - $4.27 Million	63,311 Added 5.63%	1,187,547 $66.2 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $13 Million - $17 Million	264,461 Added 30.76%	1,124,236 $72.2 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $5.33 Million - $6.31 Million	124,511 Added 16.93%	859,775 $43.6 Million
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $663,544 - $733,735	-14,871 Reduced 1.98%	735,264 $33.3 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $61,904 - $73,813	-1,372 Reduced 0.18%	750,135 $35.8 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $9.28 Million - $12 Million	-190,358 Reduced 20.21%	751,507 $39.1 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $1.95 Million - $2.2 Million	-35,266 Reduced 3.61%	941,865 $58.5 Million
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $664,570 - $828,312	-13,152 Reduced 1.33%	977,131 $54.1 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $4.75 Million - $5.47 Million	-79,257 Reduced 7.41%	990,283 $62.6 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $7.76 Million - $8.46 Million	-129,429 Reduced 10.8%	1,069,540 $65.5 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $554,509 - $639,949	10,040 Added 0.84%	1,198,969 $76.4 Million
Q2 2017 Aug 07, 2017	BUY	N/A	1,188,929	1,188,929 $66.3 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account